Position in DSGN
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$12,733
New position
Shares Held
880
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#3
of 5 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Allied Private Wealth LLC holds $175,028 across 25 Biotechnology names. DSGN ranks #5 (7.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
500 | $40,755 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
50 | $31,177 | |
| 3 | MRNA |
Moderna, Inc.
|
412 | $28,852 | |
| 4 | TECH |
BIO-TECHNE Corp
|
252 | $17,803 | |
| 5 | DSGN |
Design Therapeutics, Inc.
This page
|
880 | $12,733 | |
| 6 | FDMT |
4D Molecular Therapeutics, Inc.
|
740 | $9,842 | |
| 7 | MDXG |
Mimedx Group, Inc.
|
1,700 | $6,545 | |
| 8 | ABEO |
Abeona Therapeutics Inc.
|
900 | $5,562 |
All Filings in DSGN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,733 | 880 | Shares | Sole | 2026-07-09 | |
| No filing history on record for this holder in this stock. | ||||||